StonvexLoading…
StonvexStonvexStonvexCore line items from SHFS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.98M | $7.67M | $5.61M | $3.78M |
Operating Income | $-1.76M | $-5.40M | $-4.18M | $-2.96M |
Net Income | $-1.78M | $-2.16M | $-1.58M | $-1.76M |
EPS (Diluted) | $-0.43 | $-0.82 | $-0.56 | $-0.63 |
Total Assets | $15.69M | $17.21M | $13.66M | $5.96M |
Total Liabilities | $8.96M | $8.97M | $6.67M | $23.81M |
Cash & Equivalents | $5.90M | $6.78M | $861.72K | $247.32K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 4.35M | 2.92M | 2.92M | 2.83M |